Belsky Marc
Insider CIK 1382629 · FPRX Senior Vice President and CFO · KZR Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 12,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 29,499 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 19,499 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 13,999 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 24,500 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 17,793 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 5,999 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 5,999 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 8,999 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 21,999 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | U Tender | 2026-05-11 | 2026-05-11 | 200 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | U Tender | 2026-05-11 | 2026-05-11 | 1,538 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2025-03-27 | 2025-04-01 | 4,800 | — | $0 | 12,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2025-03-04 | 2025-03-05 | 7,200 | — | $0 | 7,200 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2025-01-09 | 2025-01-13 | 24,500 | — | $0 | 24,500 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2024-01-07 | 2024-01-09 | 295,000 | — | $0 | 295,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 195,000 | — | $0 | 195,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 195,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 140,000 | — | $0 | 140,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 140,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 220,000 | — | $0 | 220,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 60,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 60,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 90,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 90,000 | — | $0 | 90,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 220,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-01-08 | 2023-01-10 | 195,000 | — | $0 | 195,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2022-01-05 | 2022-01-07 | 140,000 | — | $0 | 140,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2021-01-08 | 2021-01-11 | 220,000 | — | $0 | 220,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2020-02-04 | 2020-02-05 | 15,384 | $2.60 | $40.0K | 15,384 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2020-01-12 | 2020-01-13 | 90,000 | — | $0 | 90,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2019-11-13 | 2019-11-13 | 800 | $2.76 | $2.2K | 2,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2019-09-06 | 2019-09-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2019-08-20 | 2019-08-21 | 200 | $4.42 | $884 | 1,200 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2019-08-09 | 2019-08-12 | 500 | $4.82 | $2.4K | 1,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2019-07-26 | 2019-07-26 | 56 | $5.80 | $325 | 500 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | P Buy | 2019-07-25 | 2019-07-26 | 444 | $5.65 | $2.5K | 444 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2019-01-06 | 2019-01-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-02-26 | 2018-02-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2018-02-26 | 2018-02-28 | 3,000 | — | $0 | 16,314 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2018-02-05 | 2018-02-07 | 1,048 | $18.42 | $19.3K | 13,314 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-09-01 | 2017-09-06 | 921 | $34.34 | $31.6K | 16,982 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-03-01 | 2017-03-03 | 18,881 | $44.77 | $845.3K | 46,785 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-02-07 | 2017-02-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2017-02-07 | 2017-02-09 | 5,625 | — | $0 | 5,625 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2017-02-07 | 2017-02-09 | 7,031 | — | $0 | 12,656 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2017-01-03 | 2017-01-05 | 2,281 | $48.60 | $110.9K | 65,666 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | F Tax w/h | 2016-09-01 | 2016-09-01 | 17,980 | $44.74 | $804.4K | 67,947 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-08-25 | 2016-08-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2016-08-25 | 2016-08-29 | 5,000 | — | $0 | 85,927 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-22 | 2016-04-26 | 12,389 | — | $0 | 17,611 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-22 | 2016-04-26 | 3,052 | — | $0 | 41,948 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-22 | 2016-04-26 | 11,178 | — | $0 | 5,082 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-22 | 2016-04-26 | 7,483 | — | $0 | 509 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-22 | 2016-04-26 | 7,483 | $5.54 | $41.5K | 88,410 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-22 | 2016-04-26 | 11,178 | $7.26 | $81.2K | 99,588 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-22 | 2016-04-26 | 12,389 | $11.14 | $138.0K | 111,977 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-22 | 2016-04-26 | 3,052 | $19.25 | $58.8K | 115,029 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-04-22 | 2016-04-26 | 33,002 | $50.03 | $1.65M | 80,927 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-04-22 | 2016-04-26 | 1,100 | $49.24 | $54.2K | 113,929 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-06 | 2016-04-08 | 11,382 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-06 | 2016-04-08 | 8,943 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-06 | 2016-04-08 | 138 | — | $0 | 7,992 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-04-06 | 2016-04-08 | 351 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-04-06 | 2016-04-08 | 20,814 | $45.04 | $937.5K | 80,927 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-06 | 2016-04-08 | 351 | $4.56 | $1.6K | 81,278 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-06 | 2016-04-08 | 11,382 | $6.89 | $78.4K | 92,660 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-06 | 2016-04-08 | 8,943 | $8.49 | $75.9K | 101,603 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-04-06 | 2016-04-08 | 138 | $5.54 | $765 | 101,741 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-03-30 | 2016-03-31 | 9,052 | — | $0 | 351 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-03-30 | 2016-03-31 | 9,052 | $4.56 | $41.3K | 89,979 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-03-30 | 2016-03-31 | 9,052 | $40.01 | $362.2K | 80,927 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise deriv | 2016-03-29 | 2016-03-31 | 4,824 | — | $0 | 9,403 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | S Sale | 2016-03-29 | 2016-03-31 | 4,824 | $40.00 | $193.0K | 80,927 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | M Exercise | 2016-03-29 | 2016-03-31 | 4,824 | $4.56 | $22.0K | 85,751 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2015-08-20 | 2015-08-21 | 75,000 | — | $0 | 80,680 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-08-17 | 2015-08-19 | 45,000 | — | $0 | 45,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2015-04-30 | 2015-05-04 | 5,680 | — | $0 | 5,680 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2014-08-22 | 2014-08-26 | 30,000 | — | $0 | 30,000 | SEC↗ |